In vitro activity of the new semi-synthetic polypeptide cilofungin (LY121019) againstAspergillus andCandida species

Manual of Clinical Microbiology

1975 • 568 citations

Aspergillosis complicating neoplastic disease

1973 • 542 citations

Fungemia in a Cancer Hospital: Changing Frequency, Earlier Onset, and Results of Therapy

1985 • 493 citations

Antifungal susceptibility tests

1987 • 152 citations

Papulacandin B: an Inhibitor of Glucan Synthesis in Yeast Spheroplasts

1979 • 135 citations

Comparison of relative susceptibilities of Candida species to three antifungal agents as determined by unstandardized methods

1987 • 118 citations

In vitro and in vivo anti-Candida activity and toxicology of LY121019.

1984 • 112 citations

Amphotericin B or ketoconazole therapy of fungal infections in neutropenic cancer patients

1987 • 67 citations

Testing of organisms for susceptibility to triazoles: Is it justified?

1989 • 54 citations

Effects of cilofungin (LY121019) on carbohydrate and sterol composition ofCandida albicans

1989 • 41 citations

Comparative in vitro activity of LY121019 and amphotericin B against clinical isolates ofCandida species

1988 • 38 citations

Treatment of experimental disseminated candidiasis with cilofungin

1989 • 21 citations

Comparative effects of cilofungin and amphotericin B on experimental murine candidiasis

1990 • 18 citations

Evaluation of cilofungin (LY121019) for treatment of experimental Candida albicans endocarditis in rabbits

1989 • 17 citations